Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2008-11-01
|
| Series: | Therapeutic Advances in Neurological Disorders |
| Online Access: | https://doi.org/10.1177/1756285608099124 |
| _version_ | 1818790270846631936 |
|---|---|
| author | J. Theodore Phillips Elliot M. Frohman |
| author_facet | J. Theodore Phillips Elliot M. Frohman |
| author_sort | J. Theodore Phillips |
| collection | DOAJ |
| first_indexed | 2024-12-18T14:52:48Z |
| format | Article |
| id | doaj.art-71e37c67af5f437c8eeff06025586931 |
| institution | Directory Open Access Journal |
| issn | 1756-2856 |
| language | English |
| last_indexed | 2024-12-18T14:52:48Z |
| publishDate | 2008-11-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Neurological Disorders |
| spelling | doaj.art-71e37c67af5f437c8eeff060255869312022-12-21T21:04:07ZengSAGE PublishingTherapeutic Advances in Neurological Disorders1756-28562008-11-01110.1177/1756285608099124Natalizumab: benefit outweighs risk in selected patients with multiple sclerosisJ. Theodore PhillipsElliot M. Frohmanhttps://doi.org/10.1177/1756285608099124 |
| spellingShingle | J. Theodore Phillips Elliot M. Frohman Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis Therapeutic Advances in Neurological Disorders |
| title | Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis |
| title_full | Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis |
| title_fullStr | Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis |
| title_full_unstemmed | Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis |
| title_short | Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis |
| title_sort | natalizumab benefit outweighs risk in selected patients with multiple sclerosis |
| url | https://doi.org/10.1177/1756285608099124 |
| work_keys_str_mv | AT jtheodorephillips natalizumabbenefitoutweighsriskinselectedpatientswithmultiplesclerosis AT elliotmfrohman natalizumabbenefitoutweighsriskinselectedpatientswithmultiplesclerosis |